768-13-8

Upstream product

• 23385-57-1 4-Chlor-2-methylmercapto-1-methoxy-benzol 
• 52807-27-9 4-chloro-2-iodo-1-methoxybenzene 
• 22952-32-5 5-chloro-2-methoxybenzenesulfonyl chloride 

Downstream Products

• 23385-53-7 4-Chloro-2-(Methylthio)-Phenol 
• 942268-42-0 2-chloro-1-[(5-chloro-2-methoxyphenyl)thio]-4-(methylsulfonyl)benzene 
• 100871-69-0 1,1'-disulfanediylbis(5-chloro-2-methoxybenzene) 
• 847147-96-0 [4-chloro-2-[[4-(ethylsulfonyl)phenyl]thio]phenoxy]-acetic acid sodium salt 
• 847148-01-0 [4-chloro-2-[[4-(ethylsulfonyl)phenyl]thio]phenoxy]-acetic acid 1,1-dimethylethyl ester 
• 847148-35-0 4-[(5-chloro-2-methoxyphenyl)thio]-N-methylbenzamide 
• 847148-00-9 4-chloro-2-[[4-(ethylsulfonyl)phenyl]thio]-phenol 
• 847148-34-9 4-[(5-chloro-2-methoxyphenyl)thio]benzoic acid 
• 23385-57-1 4-Chlor-2-methylmercapto-1-methoxy-benzol 
• 21552-52-3 [2,5-Dichloro-4-(5-chloro-2-methoxy-phenylsulfanylthiocarbonylamino)-phenyl]-dithiocarbamic acid 5-chloro-2-methoxy-phenyl ester 
• 847147-98-2 4-chloro-2-[[4-(ethylsulfonyl)phenyl]thio]-1-methoxy-benzene 

Relevant academic research and scientific papers

SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS

The present disclosure relates to compounds of formula (I) that are useful as modulators of 7α nAChR, compositions comprising such compounds, and the use of such compounds for preventing, treating, or ameliorating disease, particularly disorders of the central nervous system such as cognitive impairments in Alzheimer's disease, Parkinson's disease, and schizophrenia, as well as for L-DOPA induced-dyskinesia and inflammation.

ALPHA-D-GALACTOSIDE INHIBITORS OF GALECTINS

The present invention relates to a compound of the general formula (1). wherein the pyranose ring is a-D-galactopyranose, A is selected from The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore the present invention concerns compounds for use in a method of treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.

Substituted Diphenylethers, -Amines, -Sulfides and -Methanes for the Treatment of Respiratory Disease

The invention relates to substituted diphenylethers, -amines, -sulfides, and -methanes as useful pharmaceutical compounds for treating respiratory-disorders, pharmaceutical compositions containing them, and processes for their preparation.

PHENOXIACETIC ACID DERIVATIVES

The invention relates to certain 2-substituted phenoxyacetic acid derivatives of formula (I), in which the variables are as defined in the claims, useful in the treatment of diseases or conditions in which modulation of the CRTh2 receptor is beneficial, s